Under the category of the Generic Medicines are listed the medicines which contain the same active substance under the same pharmaceutical form as the innovative/brand medicine and are marketed after their patent/exclusivity expiry. Members of Farmavita.net are invited to publish their out-license offers in this Category.
I have two promising novel classes of anticancer drugs with first in class attributes available for in licensing.
The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.
POC : In-vitro cytotoxicactivity on human cancer cells